Emma Verner

4PUBLICATIONS
54CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study.

Adrian Minson, Emma Verner, Pratyush Giri

|Dec 08, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Mazyar Shadman, Talha Munir, Tadeusz Robak

|Sep 03, 2024
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Emma Verner, Amanda Johnston, Nalini Pati

|Oct 13, 2023
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.

Michael K Odutola, Marina T van Leeuwen, Fiona Bruinsma

Pageof 1

Frequent Collaborators

2 joint publications

John F Seymour

2 joint publications

Judith Trotman

2 joint publications

Stephen S Opat

2 joint publications

Chan Yoon Cheah